These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23998410)

  • 21. Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer.
    Verstegen NE; Maat AP; Lagerwaard FJ; Paul MA; Versteegh MI; Joosten JJ; Lastdrager W; Smit EF; Slotman BJ; Nuyttens JJ; Senan S
    Radiat Oncol; 2016 Oct; 11(1):131. PubMed ID: 27716240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of Disease Recurrence after SABR for Early Stage Non-Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy.
    Verstegen NE; Lagerwaard FJ; Hashemi SM; Dahele M; Slotman BJ; Senan S
    J Thorac Oncol; 2015 Aug; 10(8):1195-200. PubMed ID: 26200274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer.
    Roh KW; Jang JS; Kim MS; Sun DI; Kim BS; Jung SL; Kang JH; Yoo EJ; Yoon SC; Jang HS; Chung SM; Kim YS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1348-55. PubMed ID: 19117695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma.
    Low JS; Chua ET; Gao F; Wee JT
    Head Neck; 2006 Apr; 28(4):321-9. PubMed ID: 16287135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
    Dunlap NE; Larner JM; Read PW; Kozower BD; Lau CL; Sheng K; Jones DR
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):583-9. PubMed ID: 20478576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma.
    Takeda A; Sanuki N; Eriguchi T; Kobayashi T; Iwabutchi S; Matsunaga K; Mizuno T; Yashiro K; Nisimura S; Kunieda E
    J Gastroenterol Hepatol; 2014 Feb; 29(2):372-9. PubMed ID: 23927053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study.
    McGarry RC; Papiez L; Williams M; Whitford T; Timmerman RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1010-5. PubMed ID: 16115740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic radiosurgery for the treatment of lung neoplasm: experience in 100 consecutive patients.
    Pennathur A; Luketich JD; Heron DE; Schuchert MJ; Burton S; Abbas G; Gooding WE; Ferson PF; Ozhasoglu C; Gilbert S; Landreneau RJ; Christie NA
    Ann Thorac Surg; 2009 Nov; 88(5):1594-600; discussion 1600. PubMed ID: 19853118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.
    Wulf J; Haedinger U; Oppitz U; Thiele W; Mueller G; Flentje M
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):186-96. PubMed ID: 15337555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study.
    Comet B; Kramar A; Faivre-Pierret M; Dewas S; Coche-Dequeant B; Degardin M; Lefebvre JL; Lacornerie T; Lartigau EF
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):203-9. PubMed ID: 22331006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery.
    Griffioen GH; Lagerwaard FJ; Haasbeek CJ; Smit EF; Slotman BJ; Senan S
    Radiother Oncol; 2013 Jun; 107(3):403-8. PubMed ID: 23746675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
    Widder J; Klinkenberg TJ; Ubbels JF; Wiegman EM; Groen HJ; Langendijk JA
    Radiother Oncol; 2013 Jun; 107(3):409-13. PubMed ID: 23773410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent nasopharyngeal carcinoma: current management approaches.
    Smee RI; Meagher NS; Broadley K; Ho T; Williams JR; Bridger GP
    Am J Clin Oncol; 2010 Oct; 33(5):469-73. PubMed ID: 19935385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).
    Combs SE; Widmer V; Thilmann C; Hof H; Debus J; Schulz-Ertner D
    Cancer; 2005 Nov; 104(10):2168-73. PubMed ID: 16220556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC).
    Zimmermann FB; Geinitz H; Schill S; Thamm R; Nieder C; Schratzenstaller U; Molls M
    Acta Oncol; 2006; 45(7):796-801. PubMed ID: 16982542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
    Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes.
    Mattonen SA; Palma DA; Haasbeek CJ; Senan S; Ward AD
    Acta Oncol; 2013 Jun; 52(5):910-8. PubMed ID: 23106174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic Ablative Body Radiotherapy for Primary Non-Small-Cell Lung Cancer: Achieving Local Control with a Lower Biologically Effective Dose.
    Zhu S; Lightsey JL; Hoppe BS; Okunieff P; Gopalan PK; Kaye FJ; Morris CG; Yeung AR
    Cancer Invest; 2018; 36(5):289-295. PubMed ID: 30040495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.